Document:EU 2011/C 172/01 - CT-3 11-Jun-2011
From GxPlex
| Document information | |
|---|---|
| Reference | EU 2011/C 172/01 -
CT-3 11-Jun-2011 |
| Validity area | EU |
| Scope(s) | G |
| Document name | 2011/C 172/01 -
CT-3 |
| Version / Revision | 11-Jun-2011 |
| Status | Current |
| Document type | Regulatory requirement |
| Language(s) | EN |
| Description | Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from clinical trials on medicinal products for human use ( ‘CT-3’ ) |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Scope | Document part | Language | Preview | |
|---|---|---|---|---|
| EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.1 | G | Section 7 7.3.1 | EN | Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from … |
| EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.2 | G | Section 7 7.3.2 | EN | Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from … |
| EU 2011/C 172/01 - CT-3 11-Jun-2011 Section 7 7.3.3 | G | Section 7 7.3.3 | EN | Communication from the Commission — Detailed guidance on the collection, verification and presentation of adverse event/reaction reports arising from … |
